1-8 of 8
Joanna S. Yi
Close
Sort by
Journal Articles

Recurrent Hypoglycemia Following Asparaginase Therapy for Pediatric Lymphoid Malignancies

Joanna S. Yi, Mackenzie Frederick, Manal Tantoush, Alfonso Hoyos-Martinez, Michael E. Scheurer, Judith Margolin, Vince Horne
Journal: Blood
Blood (2023) 142 (Supplement 1): 5807.
https://doi.org/10.1182/blood-2023-190665
Published: 2023
Journal Articles

Venetoclax for Acute Myeloid Leukemia in Pediatric Patients: A Texas Medical Center Collaboration

Adriana Trabal, Amber Gibson, David McCall, Kris M Mahadeo, Laurie Toepfer, Michael E. Roth, Meridith Buzbee, Tapan M. Kadia, Sofia Garces, Marina Konopleva, Courtney D. DiNardo, Naval Daver, Nicholas J. Short, Ghayas C. Issa, Farhad Ravandi, Cesar Nunez, Sajad J Khazal, Hana Paek, Julienne Brackett, Guillermo Garcia-Manero, Hagop Kantarjian, Andrea N Marcogliese, ZoAnn Dreyer, Michele S. Redell, Joanna S. Yi, Alexandra McLean Stevens, Branko Cuglievan
Journal: Blood
Blood (2021) 138 (Supplement 1): 1247.
https://doi.org/10.1182/blood-2021-147379
Published: 2021
Journal Articles

An Oncogenic Enhancer Encodes Selective Selenium Dependency in AML

Charles Y Lin, PhD, Joanna S. Yi, MD, Yajian Jiang, MBBS, Daisuke Nakada, PhD, Monika Perez, BS, Jost Koren, M.S., Kenneth Eagle
Journal: Blood
Blood (2019) 134 (Supplement_1): 638.
https://doi.org/10.1182/blood-2019-129433
Published: 2019
Journal Articles

Rara Is a Druggable Super-Enhancer Regulated Dependency in Pediatric AML

Alfred S. Daramola, MS, Monika Perez, BS, Oscar S. Sias-Garcia, MS, Maci S. Terrell, BS, Helen Y Wei, BS, Nikitha Cherayil, BS, Alexandra McLean Stevens, MD PhD, Charles Y Lin, PhD, Joanna S. Yi, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 281.
https://doi.org/10.1182/blood-2019-125425
Published: 2019
Journal Articles

Transient Elevations in Markers of Hepatic Function during Pediatric Acute Lymphoblastic Leukemia Treatment Are Common but Do Not Influence Outcomes: A Study of 805 Patients from the Learn Consortium

Joanna S. Yi, MD, Tiffany Chambers, MPH, Kelly D Getz, Tamara P. Miller, MDMSc, Evanette Burrows, MPH, Marla Daves, MD, Philip J. Lupo, PhD MPH, Michael E. Scheurer, PhD MPH, Richard Aplenc, MD PhD, Karen R. Rabin, MD PhD, Maria Monica J. Gramatges, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3814.
https://doi.org/10.1182/blood-2019-123992
Published: 2019
Journal Articles

A Phase 2 Trial of Inotuzumab Ozogamicin (InO) in Children and Young Adults with Relapsed or Refractory (R/R) CD22+ B-Acute Lymphoblastic Leukemia (B-ALL): Results from Children's Oncology Group Protocol AALL1621

Maureen M O'Brien, MD, Lingyun Ji, PhD, Nirali N. Shah, MD, Susan R. Rheingold, MD, Deepa Bhojwani, MD, Joanna S. Yi, MD, Constance M. Yuan, MD PhD, Andrew C Harris, MD, Patrick A. Brown, MD, Michael J. Borowitz, MD PhD, Olga Militano, PharmD, Meenakshi Devidas, PhD, Elizabeth A. Raetz, MD, Lia Gore, MD, Mignon L. Loh, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 741.
https://doi.org/10.1182/blood-2019-128977
Published: 2019
Journal Articles

Comparing the Liver Function of Children with Acute Lymphoblastic Leukemia (ALL) Receiving Standard or High Intensity Treatment during the Interim Maintenance I Phase of Therapy: A Study of 658 Patients

Joanna S. Yi, MD, Tiffany Simone Chambers, BS, Kelly D Getz, PhD, Michael Scheurer, MPH, PhD, Philip J Lupo, PhD, Evanette Burrows, MPH, Marla Daves, MD, Richard Aplenc, MD PhD, Karen R. Rabin, MD PhD, M. Monica Gramatges, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1383.
https://doi.org/10.1182/blood-2018-99-115691
Published: 2018
Journal Articles

Structure-Guided Design of DOT1L Methyltransferase Inhibitors By a Novel, Label Free Assay Platform

Joanna S. Yi, MD, Alex Federation, Jun Qi, PhD, Sirano Dhe-Paganon, PhD, Michael Hadler, MSc, Xiang Xu, PhD, Anthony Varca, Roodolph St. Pierre, Scott A. Armstrong, MD PhD, James E. Bradner
Journal: Blood
Blood (2014) 124 (21): 4811.
https://doi.org/10.1182/blood.V124.21.4811.4811
Published: 2014